Public health. Creeping consensus on SV40 and polio vaccine. [electronic resource]
- Science (New York, N.Y.) Oct 2002
- 725-7 p. digital
Publication Type: News
1095-9203
10.1126/science.298.5594.725b doi
Advisory Committees Antibodies, Viral--blood Drug Contamination Humans National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division Neoplasms--epidemiology Poliovirus Vaccine, Inactivated--adverse effects Polyomavirus Infections--epidemiology Risk Factors Simian virus 40--immunology Time Factors Tumor Virus Infections--epidemiology United States